X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (14632) 14632
Patent (7930) 7930
Newsletter (267) 267
Book Chapter (105) 105
Magazine Article (48) 48
Book / eBook (30) 30
Dissertation (30) 30
Newspaper Article (13) 13
Conference Proceeding (9) 9
Publication (6) 6
Reference (3) 3
Web Resource (2) 2
Government Document (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
polysaccharides (14686) 14686
chemistry (8612) 8612
compositions based thereon (7930) 7930
derivatives thereof (7930) 7930
metallurgy (7930) 7930
organic macromolecular compounds (7930) 7930
their preparation or chemical working-up (7930) 7930
human necessities (7876) 7876
hygiene (7866) 7866
medical or veterinary science (7860) 7860
preparations for medical, dental, or toilet purposes (7758) 7758
specific therapeutic activity of chemical compounds ormedicinal preparations (7419) 7419
humans (6967) 6967
animals (5425) 5425
male (3129) 3129
organic chemistry (3078) 3078
mice (2800) 2800
female (2774) 2774
microbiology (2484) 2484
polysaccharides - therapeutic use (2237) 2237
pharmacology & pharmacy (2135) 2135
immunology (1940) 1940
proteins (1897) 1897
biochemistry (1813) 1813
sugars (1742) 1742
analysis (1611) 1611
polysaccharide (1564) 1564
nucleic acids (1550) 1550
specific use of cosmetics or similar toiletpreparations (1531) 1531
polysaccharides - chemistry (1498) 1498
nucleotides (1497) 1497
nucleosides (1496) 1496
polysaccharides - pharmacology (1468) 1468
biochemistry & molecular biology (1380) 1380
enzymology (1339) 1339
vinegar (1320) 1320
wine (1317) 1317
beer (1316) 1316
mutation or genetic engineering (1313) 1313
spirits (1313) 1313
medicine, research & experimental (1308) 1308
rats (1267) 1267
vaccines (1266) 1266
research (1221) 1221
health aspects (1188) 1188
adult (1166) 1166
cancer (1165) 1165
glycosylation (1139) 1139
middle aged (1092) 1092
peptides (1046) 1046
in-vitro (1009) 1009
foods or foodstuffs (1002) 1002
their treatment, not covered by other classes (1002) 1002
research article (999) 999
chemistry, medicinal (998) 998
medicine (978) 978
fermentation or enzyme-using processes to synthesise a desiredchemical compound or composition or to separate optical isomersfrom a racemic mixture (964) 964
chemical aspects of bandages, dressings, absorbent pads, orsurgical articles (951) 951
disinfection, sterilisation, or deodorisation of air (951) 951
materials for bandages, dressings, absorbent pads, or surgicalarticles (951) 951
methods or apparatus for sterilising materials or objects ingeneral (951) 951
foods, foodstuffs, or non-alcoholic beverages, not covered bysubclasses a23b - a23j (930) 930
preservation of foods or foodstuffs, in general (930) 930
their preparation or treatment, e.g. cooking, modification ofnutritive qualities, physical treatment (930) 930
multidisciplinary sciences (908) 908
biotechnology & applied microbiology (904) 904
aged (901) 901
expression (866) 866
inflammation (860) 860
carbohydrates (845) 845
polysaccharides - metabolism (819) 819
bacteria (813) 813
enzymes (803) 803
biology (788) 788
vaccination (773) 773
studies (768) 768
apoptosis (756) 756
cells (742) 742
antigens (721) 721
disease (720) 720
immunization (712) 712
antibodies (706) 706
physiological aspects (688) 688
life sciences (687) 687
science (684) 684
compositions of macromolecular compounds (681) 681
saccharides (668) 668
biotechnology (664) 664
antioxidants (661) 661
infections (658) 658
chemistry, multidisciplinary (648) 648
glycoproteins (642) 642
infectious diseases (637) 637
culture media (629) 629
care and treatment (627) 627
disease models, animal (621) 621
gene expression (600) 600
molecular weight (597) 597
anticoagulants - therapeutic use (595) 595
cell biology (589) 589
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (20876) 20876
French (2229) 2229
German (1452) 1452
Chinese (638) 638
Japanese (494) 494
Spanish (326) 326
Russian (294) 294
Portuguese (188) 188
Korean (176) 176
Danish (110) 110
Norwegian (105) 105
Finnish (96) 96
Polish (83) 83
Italian (75) 75
Swedish (68) 68
Hungarian (56) 56
Czech (54) 54
Slovenian (26) 26
Slovak (25) 25
Dutch (21) 21
Greek (16) 16
Croatian (13) 13
Serbian (13) 13
Bulgarian (12) 12
Ukrainian (12) 12
Estonian (10) 10
Hebrew (10) 10
Icelandic (10) 10
Lithuanian (9) 9
Turkish (9) 9
Romanian (8) 8
Arabic (7) 7
Latvian (4) 4
Indonesian (2) 2
Bosnian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Thrombosis and Haemostasis, ISSN 0340-6245, 09/2015, Volume 113, Issue 5, pp. 931 - 942
Summary Several new anticoagulants have entered the clinical arena or are under clinical development. These drugs include indirect (fondaparinux) and direct... 
Review Article | Rivaroxaban | Antidotes | Dabigatran | New anticoagulants | Apixaban | ANDEXANET-ALPHA | VITAMIN-K ANTAGONISTS | rivaroxaban | apixaban | ATRIAL-FIBRILLATION | antidotes | IN-VITRO | ANTIIDIOTYPIC ANTIBODIES | PROTHROMBIN COMPLEX CONCENTRATE | ORAL ANTICOAGULANTS | MOLECULAR-WEIGHT HEPARIN | dabigatran | PERIPHERAL VASCULAR DISEASE | HEALTHY-VOLUNTEERS | HEMATOLOGY | ACUTE VENOUS THROMBOEMBOLISM | Recombinant Proteins - therapeutic use | Pyrazoles - therapeutic use | Anticoagulants - administration & dosage | Thrombosis - complications | Humans | Antibodies, Monoclonal - therapeutic use | Heparin - therapeutic use | Hemorrhage - prevention & control | Thiazoles - therapeutic use | Dabigatran - therapeutic use | Vitamin K - antagonists & inhibitors | Benzamides - therapeutic use | Anticoagulants - chemistry | Factor Xa - therapeutic use | Intracranial Hemorrhages - prevention & control | Rivaroxaban - therapeutic use | Pyridines - therapeutic use | Polysaccharides - therapeutic use | Hemostatics - chemistry | Antibodies, Monoclonal, Humanized - therapeutic use | Administration, Oral | Antithrombins - therapeutic use | Infusions, Parenteral | Clinical Trials as Topic | Factor Xa Inhibitors - therapeutic use | Animals | Protamines - therapeutic use | Pyridones - therapeutic use | Thrombosis - drug therapy | Hemorrhage - chemically induced | Hemostatics - therapeutic use
Journal Article
American Heart Journal, ISSN 0002-8703, 2014, Volume 168, Issue 5, pp. 611 - 621
.... Anticoagulation uses 1 of 4 choices: bivalirudin, unfractionated heparin, enoxaparin, and fondaparinux... 
Cardiovascular | WORKING GROUP | CARDIAC & CARDIOVASCULAR SYSTEMS | ANTITHROMBOTIC THERAPY | DOUBLE-BLIND | ASSOCIATION TASK-FORCE | EUROPEAN-SOCIETY | ELEVATION MYOCARDIAL-INFARCTION | CONSENSUS DOCUMENT | PLATELET REACTIVITY | ATRIAL-FIBRILLATION | UNFRACTIONATED HEPARIN | Recombinant Proteins - therapeutic use | Prasugrel Hydrochloride | Thiophenes - therapeutic use | Hirudins | Humans | Heparin - therapeutic use | Enoxaparin - therapeutic use | Tyrosine - analogs & derivatives | Receptors, Thrombin - antagonists & inhibitors | Warfarin - therapeutic use | Tyrosine - therapeutic use | Adenosine - therapeutic use | Aspirin - therapeutic use | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Purinergic P2Y Receptor Antagonists - therapeutic use | Pyridines - therapeutic use | Polysaccharides - therapeutic use | Anticoagulants - therapeutic use | Piperazines - therapeutic use | Adenosine Monophosphate - therapeutic use | Lactones - therapeutic use | Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors | Acute Coronary Syndrome - drug therapy | Adenosine - analogs & derivatives | Adenosine Monophosphate - analogs & derivatives | Peptide Fragments - therapeutic use | Peptides - therapeutic use | Aspirin | Glycosaminoglycans | Atrial fibrillation | Mortality | Thrombin | Anticoagulants (Medicine) | Health aspects | Drug approval | Coronary heart disease | Heart attacks | Acute coronary syndromes | Drug therapy | Clinical outcomes
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 01/2018, Volume 2019, Issue 2, p. CD006649
...; checking of references of included studies; use of the 'related citation' feature in PubMed... 
'ORPHAN' TOPICS CURRENTLY BEING ADDRESSED | Anticoagulants | Recurrence | Tinzaparin | Secondary Prevention | Heparin, Low‐Molecular‐Weight | Fibrinolytic Agents | Hemorrhage | Neoplasms | Randomized Controlled Trials as Topic | Thrombophilia & other causes of thrombosis | Polysaccharides | Venous Thromboembolism | Dalteparin | Treatment of miscellaneous conditions in cancer | Fondaparinux | Heparin | Heart & circulation | Medicine General & Introductory Medical Sciences | Thrombo‐embolism prevention & treatment | General cancer treatments | Cancer | Fibrinolytic Agents [therapeutic use] | EXTERNAL PNEUMATIC COMPRESSION | RISK-FACTORS | STANDARD HEPARIN | Venous Thromboembolism [drug therapy; mortality] | Humans | RANDOMIZED CLINICAL-TRIAL | LOW-MOLECULAR-WEIGHT | DEEP-VEIN THROMBOSIS | INTRAVENOUS UNFRACTIONATED HEPARIN | FACTOR-BEARING MICROPARTICLES | MEDICINE, GENERAL & INTERNAL | PHASE-II TRIAL | Polysaccharides [therapeutic use] | Dalteparin [therapeutic use] | LONG-TERM TINZAPARIN | Heparin [therapeutic use] | Heparin, Low-Molecular-Weight [therapeutic use] | Neoplasms [complications] | Anticoagulants [therapeutic use] | Polysaccharides - therapeutic use | Venous Thromboembolism - mortality | Anticoagulants - therapeutic use | Heparin - therapeutic use | Heparin, Low-Molecular-Weight - therapeutic use | Venous Thromboembolism - drug therapy | Neoplasms - complications | Dalteparin - therapeutic use | Fibrinolytic Agents - therapeutic use | Hemorrhage - chemically induced
Journal Article
Marine drugs, ISSN 1660-3397, 2019, Volume 17, Issue 9, p. 487
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 04/2016, Volume 75, Issue 4, pp. 687 - 695
Journal Article
Seminars in Cancer Biology, ISSN 1044-579X, 2015, Volume 35, pp. S185 - S198
Journal Article